Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 AMRI Expands Portfolio | Contract Pharma

What are you searching for?

Sign in
Breaking News

AMRI Expands Portfolio

To unveil APIs and capabilities at CPhI

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AMRI is showcasing its comprehensive portfolio of active pharmaceutical ingredients (APIs) and capabilities at CPhI Worldwide this week. AMRI’s July 2016 acquisition of Euticals positions AMRI as one of the largest independent developers and suppliers of API to the pharmaceutical industry and provides the company with an established presence in key European markets.

AMRI provides a broad range of complex API to the life sciences industry, including sterile and high potency APIs, steroids, generics, monobactams, boronic acids and controlled substances.

“As AMRI celebrates its 25th anniversary, CPhI presents the perfect opportunity to reveal AMRI and Euticals as one combined company that can offer a greatly expanded portfolio of market-leading APIs and world-class capabilities in niche and high-barrier-to-entry technologies,” said Margalit Fine, executive vice president of API, AMRI. “In addition to an extensive API portfolio, we can now offer our customers U.S. and European-based chemical development expertise for early stage compounds, custom synthesis and contract manufacturing expertise, as well as extensive technology expertise in specialty areas such as hydrogenation, fermentation, photocatalytic chemistry, bio transformation, industrial chromatography, flow chemistry and spray drying.”
AMRI Expands Portfolio

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters